CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Other events
- 4 Shares withheld for taxes President and CEO gave up 10,980 shares (to pay taxes)
- 4 Planned sale Head of Development sold 2,660 shares at $199.83 ($531,548)
- 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 3,339 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,543 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Corporate Development gave up 1,583 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Global Product Strat. gave up 2,038 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Research gave up 991 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Human Resources gave up 2,589 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 359 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Chief Legal Officer gave up 3,504 shares (to pay taxes)
- 144 Insider Sale of Securities
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale Head of Development sold 748 shares at $179.30 ($134,116)
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 4 Shares withheld for taxes President and CEO gave up 3,404 shares (to pay taxes)
Page 4 of 137 · 2,721 filings